Concepedia

Kamlesh Sodani

KS

22

Publications

1.1K

Citations

19

H-Index

2009

Active since

Affiliations

St. John's University(Current)

Sun Yat-sen University

Sun Yat-sen University Cancer Center

National Cancer Institute

Center for Cancer Research

Kamlesh Sodani is an author at St. John's University specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug ResistancePharmacotherapyMolecular PharmacologyCell BiologyBiochemistryTumor BiologyCancer Research

Publications per year

2009–2025

22

Publications

22

Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

Amit K. Tiwari, Kamlesh Sodani, Si‐Rong Wang et al. · Biochemical Pharmacology · 2009 · 207 citations

Molecular Pharmacology, Drug Resistance Analysis, Biochemistry +9

Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models

Amit K. Tiwari, Kamlesh Sodani, Chun-ling Dai et al. · Cancer Letters · 2012 · 138 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Drug Target +12

Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance

Yehong Kuang, Tong Shen, Xiang Chen et al. · Biochemical Pharmacology · 2009 · 98 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Potent Reversal Agents +9

GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance

Kamlesh Sodani, Amit K. Tiwari, Satyakam Singh et al. · Biochemical Pharmacology · 2012 · 61 citations · Full text

Molecular Pharmacology, Tumor Biology, Abcb1-mediated Drug Resistance +13

PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR

Nagaraju Anreddy, Atish Patel, Kamlesh Sodani et al. · Acta Pharmaceutica Sinica B · 2014 · 51 citations · Full text

Rows per page

1–5 of 22